Press release
MRNA Based Vaccines and Therapeutics Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight | Pfizer Inc., BioNTech SE, Moderna, Inc., Gennova Biopharmaceuticals Limited, GSK plc., Daiichi Sankyo, Arcturus, Bo
MRNA Based Vaccines and Therapeutics Market
Discover which therapies are expected to grab the MRNA Based Vaccines and Therapeutics Market Share @ MRNA Based Vaccines and Therapeutics Market Outlook- https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the MRNA Based Vaccines and Therapeutics Market Report
• In March 2025, GlaxoSmithKline announced a study is to assess the safety and immune response of GlaxoSmithKlines (GSK) messenger RNA (mRNA)-based multivalent vaccine (GSK4382276A) candidate against influenza, administered in healthy younger adults (YA) and older adults (OA).
• In March 2025, Sanofi conducted a study is to evaluate the safety and immunogenicity of a human metapneumovirus (hMPV) / respiratory syncytial virus (RSV) mRNA vaccine candidate encapsulated in a lipid nanoparticle (LNP) based formulation (hereafter referred to as hMPV/RSV vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by hMPV and/or RSV among adults aged 60 years and older.
• The increase in MRNA Based Vaccines and Therapeutics Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the MRNA Based Vaccines and Therapeutics Market is anticipated to witness growth at a considerable CAGR.
• The leading MRNA Based Vaccines and Therapeutics Companies such as Pfizer Inc., BioNTech SE, Moderna, Inc., Gennova Biopharmaceuticals Limited, GSK plc., Daiichi Sankyo, Arcturus, Boehringer Ingelheim International GmbH, Ethris GmbH, CureVac SE, AIM Vaccine Corporation, Charoen Pokphand Group, Argos Therapeutics Inc., Sanofi, Kernal Biologics Inc, and others, and others
• Promising MRNA Based Vaccines and Therapeutics Pipeline Therapies such as VX-522, RCT1100, mRNA-4157, REM-422, scAAV9.U7.ACCA, PF-06651600, STP705, PTW-002 10, Enzalutamide, JCXH-221, BIVV003, bbT369, HBI-002, SLN124, STC-15, BNT112, AGMB-129, ALN-HSD, JNJ-55308942, AZD8701, BBV152, MCLA-158, SAR441000, ITI-1000, and others.
Stay ahead in the MRNA Based Vaccines and Therapeutics Market with DelveInsight's Strategic Report @ MRNA Based Vaccines and Therapeutics Market Outlook- https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
MRNA Based Vaccines and Therapeutics Epidemiology Segmentation in the 7MM
The epidemiology section of MRNA Based Vaccines and Therapeutics offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
• Total Incident Cases of Shortlisted Indications for mRNA Therapy for Oncology
• Total Indication-wise Eligible Cases for mRNA Therapy for Oncology
• Indication-wise Treated Cases of mRNA Therapy for Oncology
Download the report to understand which factors are driving MRNA Based Vaccines and Therapeutics Epidemiology trends @ MRNA Based Vaccines and Therapeutics Prevalence- https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
MRNA Based Vaccines and Therapeutics Drugs Market
The MRNA Based Vaccines and Therapeutics Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying MRNA Based Vaccines and Therapeutics signaling in MRNA Based Vaccines and Therapeutics are likely to uncover new therapeutic targets and further expand treatment options for patients.
MRNA Based Vaccines and Therapeutics Treatment Market Landscape
The MRNA Based Vaccines and Therapeutics treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of MRNA Based Vaccines and Therapeutics has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about MRNA Based Therapeutics treatment guidelines, visit @ MRNA Based Therapeutics Treatment Market Landscape- https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
MRNA-Based Therapeutics Pipeline Therapies and Companies
• VX-522: Vertex Pharmaceuticals Incorporated
• RCT1100: ReCode Therapeutics
• mRNA-4157: ModernaTX, Inc./Merck Sharp & Dohme LLC
• REM-422: Remix Therapeutics
• scAAV9.U7.ACCA: Audentes Therapeutics
• PF-06651600: Pfizer
• STP705: Sirnaomics
• PTW-002 10: Phoenicis Therapeutics
• Enzalutamide: Astellas Pharma US, Inc.
• JCXH-221: Immorna Biotherapeutics, Inc./ICON plc
• BIVV003: Sangamo Therapeutics
• bbT369: 2seventy bio
• HBI-002: Hillhurst Biopharmaceuticals, Inc.
• SLN124: Silence Therapeutics plc
• STC-15: STORM Therapeutics LTD
• BNT112: BioNTech SE
• AGMB-129: Agomab Therapeutics NV
• ALN-HSD: Alnylam Pharmaceuticals
• JNJ-55308942: Janssen Pharmaceutica N.V.
• AZD8701: AstraZeneca
• BBV152: Ocugen
• MCLA-158: Merus N.V.
• SAR441000: Sanofi
• ITI-1000: Immunomic Therapeutics
MRNA Based Therapeutics Market Outlook
The report's outlook on the MRNA Based Vaccines and Therapeutics market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing MRNA Based Vaccines and Therapeutics therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed MRNA Based Therapeutics drug and late-stage pipeline therapy.
MRNA Based Therapeutics Drugs Uptake
The drug chapter of the MRNA Based Therapeutics report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to MRNA Based Vaccines and Therapeutics.
MRNA Based Vaccines and Therapeutics Market Dynamics
The dynamics of the global mRNA-based therapeutics market are expected to change in the coming years. Several mRNA-based vaccine candidates currently in pre-clinical and clinical phases of development are poised to drive the mRNA-based vaccines and therapeutics market in upcoming years, as the field of mRNA-based therapeutics spans from protein replacement therapy and gene editing to vaccination, and continued advancements in mRNA formulation and delivery using different nanomaterials hold the potential to improve the wider use of mRNA for the treatment and prevention of infectious diseases and cancers.
Major MRNA Based Therapeutics Companies
Pfizer Inc., BioNTech SE, Moderna, Inc., Gennova Biopharmaceuticals Limited, GSK plc., Daiichi Sankyo, Arcturus, Boehringer Ingelheim International GmbH, Ethris GmbH, CureVac SE, AIM Vaccine Corporation, Charoen Pokphand Group, Argos Therapeutics Inc., Sanofi, Kernal Biologics Inc, and others, and others
Learn more about the FDA-approved drugs for MRNA Based Vaccines and Therapeutics @ Drugs for MRNA Based Vaccines and Therapeutics Treatment- https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the MRNA Based Vaccines and Therapeutics Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• MRNA Based Vaccines and Therapeutics Companies- Pfizer Inc., BioNTech SE, Moderna, Inc., Gennova Biopharmaceuticals Limited, GSK plc., Daiichi Sankyo, Arcturus, Boehringer Ingelheim International GmbH, Ethris GmbH, CureVac SE, AIM Vaccine Corporation, Charoen Pokphand Group, Argos Therapeutics Inc., Sanofi, Kernal Biologics Inc, and others, and others
• MRNA Based Vaccines and Therapeutics Pipeline Therapies- VX-522, RCT1100, mRNA-4157, REM-422, scAAV9.U7.ACCA, PF-06651600, STP705, PTW-002 10, Enzalutamide, JCXH-221, BIVV003, bbT369, HBI-002, SLN124, STC-15, BNT112, AGMB-129, ALN-HSD, JNJ-55308942, AZD8701, BBV152, MCLA-158, SAR441000, ITI-1000, and others.
• MRNA Based Vaccines and Therapeutics Market Dynamics: MRNA Based Vaccines and Therapeutics Market Drivers and Barriers
• MRNA Based Vaccines and Therapeutics Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about MRNA Based Therapeutics Drugs in development @ MRNA Based Vaccines and Therapeutics Clinical Trials Assessment- https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. MRNA Based Vaccines and Therapeutics Executive Summary
3. MRNA Based Vaccines and Therapeutics Competitive Intelligence Analysis
4. MRNA Based Vaccines and Therapeutics: Market Overview at a Glance
5. MRNA Based Vaccines and Therapeutics: Disease Background and Overview
6. Patient Journey
7. MRNA Based Vaccines and Therapeutics Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. MRNA Based Vaccines and Therapeutics Unmet Needs
10. Key Endpoints of MRNA Based Vaccines and Therapeutics Treatment
11. MRNA Based Vaccines and Therapeutics Marketed Products
12. MRNA Based Vaccines and Therapeutics Emerging Therapies
13. MRNA Based Vaccines and Therapeutics: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: MRNA Based Vaccines and Therapeutics Market Outlook
16. Access and Reimbursement Overview of MRNA Based Vaccines and Therapeutics
17. KOL Views
18. MRNA Based Vaccines and Therapeutics Market Drivers
19. MRNA Based Vaccines and Therapeutics Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
List of Top Selling Market Research Reports in 2025
NK Cell Therapy Market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Psoriasis Vulgaris Market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
Surgical Energy Instruments Market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Immune Checkpoints Activators Market- https://www.delveinsight.com/report-store/immune-checkpoint-inhibitors-market
Vitreoretinal Surgery Devices Market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Cystic Fibrosis Market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Surgical Robotic System Market- https://www.delveinsight.com/report-store/surgical-robotic-system-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market
Diabetic Wound Market- https://www.delveinsight.com/report-store/diabetic-wounds-market
Indwelling Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market
Attention Deficit Hyperactivity Disorder Market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Overactive Bladder Syndrome Market- https://www.delveinsight.com/report-store/underactive-bladder-market
Stem Cell Market- https://www.delveinsight.com/report-store/stem-cell-market
Healthcare Competitive Benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Thyroid Cancer Market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Antibody Drug Conjugate Market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Surgical Mask & Respirator Market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Total Knee Arthroplasty Market - https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Bone Growth Stimulator Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MRNA Based Vaccines and Therapeutics Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight | Pfizer Inc., BioNTech SE, Moderna, Inc., Gennova Biopharmaceuticals Limited, GSK plc., Daiichi Sankyo, Arcturus, Bo here
News-ID: 3973028 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
